Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

NCT05248633 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Solitary Plasmacytoma

Interventions

RADIATION: radiotherapy
DRUG: Bortezomib Injection
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Peking Union Medical College Hospital